Use of orally absorbable motilin preparations to enhance motility of digestive tract
US5468728A · kind A · utility
9Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1993 |
| Grant date | Nov 21, 1995 |
| Priority date | — |
| Expiry date | Sep 8, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A readily absorbable type of motilin preparation containing a motilin-like active substance and a surface active agent is provided, in which the motilin-like active substance is mainly L-leucine-13-motilin-homoserine, and the surface active agent is selected from the group consisting of a bile salt, saponin and a polyethylene glycol higher-alcohol ether for nasal administration purposes and is a peptide lytic enzyme inhibitor for oral administration purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.